TP53 and myelodysplastic syndrome: Although by definition, MDS-SF3B1 and MDS-del(5q) (or MDS-5q) are lower risk entities and MDS-biTP53 (or MDS with mutated TP53) is a high-risk entity, these genetically defined subtypes make up a modest proportion of patients with MDS.